Today: 19 June 2026

TeraWulf stock jumps nearly 11% as bitcoin steadies near $91,000 — what WULF traders watch next

TeraWulf stock jumps nearly 11% as bitcoin steadies near $91,000 — what WULF traders watch next

TeraWulf shares jumped 10.9% to $12.74 Friday, with about 26 million shares traded, after SEC filings showed large restricted-stock awards to top executives. Bitcoin hovered near $91,000, lifting mining stocks including Marathon Digital, Riot Platforms, and CleanSpark. A recent filing detailed a $1.3 billion private note offering for a Texas data-center project.
4 January 2026
···
Hut 8 stock jumps 12% as bitcoin rallies and Coinbase credit line returns to focus

Hut 8 stock jumps 12% as bitcoin rallies and Coinbase credit line returns to focus

Hut 8 shares jumped 11.6% to $51.27 Friday after the company expanded a bitcoin-backed credit facility with Coinbase Credit to $200 million and drew the full amount. Trading volume reached 6.5 million shares. Peers Marathon Digital, Riot Platforms, and Applied Digital also rose sharply. Hut 8 said it will use the funds for general corporate purposes, secured by bitcoin held with Coinbase Custody.
4 January 2026
···
RIOT stock jumps after Riot Platforms names new CFO and ties bonuses to data-center deals

RIOT stock jumps after Riot Platforms names new CFO and ties bonuses to data-center deals

Riot Platforms shares jumped nearly 12% to $14.16 Friday after the company named Jason Chung as incoming CFO, replacing Colin Yee, who will become a senior advisor. A filing showed Riot removed a bitcoin-focused metric from its 2026 incentive plan, adding data-center revenue and NOI measures once it secures a tenant. CEO and executive chairman base salaries rose to $900,000. Bitcoin traded around $91,356.
4 January 2026
·
Centrus Energy stock leaps 12% to start 2026 as uranium names rally — what investors watch next

Centrus Energy stock leaps 12% to start 2026 as uranium names rally — what investors watch next

Centrus Energy shares surged 12.2% to $272.50 in the first U.S. trading session of 2026, with over 1 million shares changing hands. The move followed a broad rally in uranium stocks as Centrus, the only U.S. producer of high-assay low-enriched uranium, hit a 900-kilogram production milestone at its Ohio plant. The Dow rose 0.66%, S&P 500 gained 0.19%, and Nasdaq slipped 0.03%.
4 January 2026
··
Bloom Energy stock jumps 14% to start 2026 as fuel-cell names rebound — what investors watch next

Bloom Energy stock jumps 14% to start 2026 as fuel-cell names rebound — what investors watch next

Bloom Energy jumped 13.6% to $98.69 Friday, with over 11 million shares traded after a volatile session. Plug Power and FuelCell Energy also posted double-digit gains. The rally followed Bloom’s disclosure of a new $600 million credit facility and came as investors await key U.S. jobs and inflation data next week. The S&P 500 closed up 0.19%, while the Nasdaq slipped 0.03%.
4 January 2026
···
AAOI stock jumps 14% to start 2026 as Applied Optoelectronics rides AI data-center demand

AAOI stock jumps 14% to start 2026 as Applied Optoelectronics rides AI data-center demand

Applied Optoelectronics surged 13.6% to $39.60 Friday, leading gains among optical hardware stocks as investors rotated into AI-infrastructure trades. The company last month reported its first volume order for 800G data-center transceivers and forecast up to $8 million in Q4 revenue from those shipments. Volume production of a new 400-milliwatt pump laser is expected later in 2026.
4 January 2026
····
Baidu stock jumps nearly 15% after AI chip unit Kunlunxin files for Hong Kong IPO

Baidu stock jumps nearly 15% after AI chip unit Kunlunxin files for Hong Kong IPO

Baidu’s U.S.-listed shares jumped 14.9% to $150.30 Friday after confirming its AI chip unit Kunlunxin filed confidentially for a Hong Kong listing. The spin-off remains subject to regulatory approvals and final terms. Traders are watching for updates on timing, valuation, and potential follow-through when U.S. markets reopen Monday.
4 January 2026
····
NuScale Power stock jumps 15% to start 2026 as nuclear names rally — what to watch Monday

NuScale Power stock jumps 15% to start 2026 as nuclear names rally — what to watch Monday

NuScale Power shares jumped 15.1% to $16.31 Friday on heavy volume, tracking gains across nuclear stocks and uranium ETFs. Oklo, Centrus Energy, and BWX Technologies also rose. Finland’s Olkiluoto 2 nuclear unit was resynchronized to the grid after a 17-hour shutdown during a software update. The U.S. Energy Department in December pledged up to $800 million for small modular reactor projects.
4 January 2026
····
American Airlines stock: What investors are watching after FAA Caribbean airspace shutdown

American Airlines stock: What investors are watching after FAA Caribbean airspace shutdown

The FAA closed parts of Caribbean airspace to U.S. carriers after a U.S. military operation in Venezuela, causing widespread flight cancellations Saturday. American Airlines shares last closed up 0.98% at $15.48. Traders are watching for updates on the duration of the restrictions and possible disruptions into Monday’s open.
4 January 2026
·····
Fluence Energy stock jumps 16% to kick off 2026 as AI-power demand lifts storage names

Fluence Energy stock jumps 16% to kick off 2026 as AI-power demand lifts storage names

Fluence Energy shares jumped 16.3% Friday to close at $23.01, trading between $20.14 and $23.12. The rally followed investor interest in AI-driven power demand and energy storage. Peers Stem and Sunrun also gained, while Tesla slipped. Fluence is set to report earnings on Feb. 9, with focus on revenue backlog and fiscal 2026 targets.
4 January 2026
···
1 … 1,035 1,036 1,037 1,038 1,039 … 2,085

Stock Market Today

  • uniQure Shares Surge 78% on FDA Support for AMT-130 Accelerated Approval
    June 19, 2026, 3:49 PM EDT. uniQure's stock jumped 78.4% after the FDA indicated that three-year phase I/II data for AMT-130, a gene therapy for Huntington's disease, could support a biologics license application (BLA) for accelerated approval. The FDA requested alignment on a confirmatory study design, favoring a control group over sham surgery, with plans expected before a 2026 Q3 BLA filing. This update follows earlier regulatory setbacks when the FDA questioned the sufficiency of phase I/II data compared to external controls. AMT-130 uses gene-silencing microRNA to target the huntingtin gene. The therapy is evaluated in ongoing phase I/II trials assessing safety and efficacy. uniQure aims to begin confirmatory studies promptly under FDA collaboration.

Latest articles

WELL Health slides as TSX holds steady; Circle Medical, cash flow draw attention

WELL Health slides as TSX holds steady; Circle Medical, cash flow draw attention

19 June 2026
WELL Health plunged 3.7% to C$4.19 in Toronto as investors looked past director election results and focused on falling Q1 operating adjusted free cash flow, which dropped to C$1.6 million from C$11.8 million a year earlier due to clinic investments, higher cash taxes, Circle Medical deferrals, and increased interest payments.
MDA Space stock rises as Blue Canyon deal targets U.S. defense market

MDA Space stock rises as Blue Canyon deal targets U.S. defense market

19 June 2026
MDA Space’s Toronto shares jumped 4.4% to C$58.08 after it agreed to buy Blue Canyon Technologies from RTX’s Raytheon for US$620 million cash, a move aimed at expanding access to U.S. defense-space work and classified programs; the deal is expected to add to adjusted EBITDA and EPS in 2027 but faces regulatory approval and integration risks.
Fermi rally stalls with Nasdaq closed for Juneteenth as proxy fight simmers

Fermi rally stalls with Nasdaq closed for Juneteenth as proxy fight simmers

19 June 2026
Fermi surged 10% to $9.50 before the Juneteenth market closure, fueled by speculation of a potential OpenAI-related customer for its Project Matador campus, but no binding tenant deal has been announced, leaving the rally exposed to profit-taking if a concrete agreement or joint venture isn’t revealed when trading resumes.
Go toTop